Patents by Inventor Mark McLaws

Mark McLaws has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9481649
    Abstract: The invention describes an improved synthesis for piperazine derivatized with nicotinic acid and a benzyl moiety. The product compounds are useful for treatment of neurological conditions.
    Type: Grant
    Filed: December 9, 2015
    Date of Patent: November 1, 2016
    Assignee: NEURALSTEM, INC.
    Inventors: Sripathy Venkatraman, Syed Mahmood, Bingidimi I. Mobele, Olga Lapina, Kellie Vercoe, Ying Li, Jonathan Salsbury, Mark McLaws
  • Publication number: 20160090358
    Abstract: The invention describes an improved synthesis for piperazine derivatized with nicotinic acid and a benzyl moiety. The product compounds are useful for treatment of neurological conditions.
    Type: Application
    Filed: December 9, 2015
    Publication date: March 31, 2016
    Applicant: NEURALSTEM, INC.
    Inventors: Sripathy VENKATRAMAN, Syed MAHMOOD, Bingidimi I. MOBELE, Olga LAPINA, Kellie VERCOE, Ying LI, Jonathan SALSBURY, Mark MCLAWS
  • Publication number: 20160090361
    Abstract: The present invention is related to a two-step carboxylation reaction of an aryl group using continuous flow reaction conditions. This process permits large scale synthesis of useful reaction products in high yield.
    Type: Application
    Filed: September 25, 2015
    Publication date: March 31, 2016
    Inventors: Scott Tweedie, Sripathy Venkatraman, Shuhong Liu, James Zeller, Elisabeth Brot, Michael Hamlin, Mary Newman, Mark McLaws, John Rosenberg, David Lathbury
  • Patent number: 9278933
    Abstract: The invention describes an improved synthesis for piperazine derivatized with nicotinic acid and a benzyl moiety. The product compounds are useful for treatment of neurological conditions.
    Type: Grant
    Filed: August 24, 2010
    Date of Patent: March 8, 2016
    Assignee: NEURALSTEM, INC.
    Inventors: Sripathy Venkatraman, Syed Mahmood, Bingidimi I. Mobele, Olga Lapina, Kellie Vercoe, Ying Li, Jonathan Salsbury, Mark McLaws
  • Publication number: 20130005974
    Abstract: The invention describes an improved synthesis for piperazine derivatized with nicotinic acid and a benzyl moiety. The product compounds are useful for treatment of neurological conditions.
    Type: Application
    Filed: August 24, 2010
    Publication date: January 3, 2013
    Applicant: NEURALSTEM, INC.
    Inventors: Sripathy Venkatraman, Syed Mahmood, Bingidimi I. Mobele, Olga Lapina, Kellie Vercoe, Ying Li, Jonathan Salsbury, Mark McLaws
  • Patent number: 8148548
    Abstract: A heterocyclic fused selenophenes and a method of making a heterocyclic fused selenophenes of formula (1): wherein X is S or Se, Y is S or Se, wherein one or both of X and Y is Se, R is a substituent group. The monomer being capable of polymerization to form an electrically conductive polymer or oligomer.
    Type: Grant
    Filed: January 14, 2009
    Date of Patent: April 3, 2012
    Assignee: Konarka Technologies, Inc.
    Inventors: Steffen Zahn, Richard V. C. Carr, Roberta Kathleen Hause, Carrie A. Costello, Mark Mclaws
  • Patent number: 7982055
    Abstract: A heterocyclic fused selenophenes and a method of making a heterocyclic fused selenophenes of formula (1): wherein X is S or Se, Y is S or Se, wherein one or both of X and Y is Se, R is a substituent group. The monomer being capable of polymerization to form an electrically conductive polymer or oligomer.
    Type: Grant
    Filed: July 13, 2007
    Date of Patent: July 19, 2011
    Assignee: Konarka Technologies, Inc.
    Inventors: Steffen Zahn, Carrie A. Costello, Mark McLaws
  • Publication number: 20090143599
    Abstract: A heterocyclic fused selenophenes and a method of making a heterocyclic fused selenophenes of formula (1): wherein X is S or Se, Y is S or Se, wherein one or both of X and Y is Se, R is a substituent group. The monomer being capable of polymerization to form an electrically conductive polymer or oligomer.
    Type: Application
    Filed: January 14, 2009
    Publication date: June 4, 2009
    Applicant: AIR PRODUCTS AND CHEMICALS, INC.
    Inventors: Steffen Zahn, Richard V.C. Carr, Roberta Kathleen Hause, Carrie A. Costello, Mark Mclaws
  • Publication number: 20090018348
    Abstract: A heterocyclic fused selenophenes and a method of making a heterocyclic fused selenophenes of formula (1): wherein X is S or Se, Y is S or Se, wherein one or both of X and Y is Se, R is a substituent group. The monomer being capable of polymerization to form an electrically conductive polymer or oligomer.
    Type: Application
    Filed: July 13, 2007
    Publication date: January 15, 2009
    Applicant: Air Products and Chemicals, Inc.
    Inventors: Steffen Zahn, Carrie A. Costello, Mark McLaws
  • Publication number: 20060276372
    Abstract: A method and system used for treating proliferative disorders using carotenoids, carotenoid analogs, and/or carotenoid derivatives. The method and system may be used for chemoprevention and/or chemotherapy. The method and system may induce apoptosis in target cells, tissues, and/or organs. The analog, derivative, or intermediate may be administered to a cell, a group of cells, a tissue, an organ or a subject, such that at least a portion of the undesirable consequences of the proliferative disorder are thereby reduced.
    Type: Application
    Filed: March 9, 2006
    Publication date: December 7, 2006
    Inventors: Samuel Lockwood, Geoff Nadolski, Dean Frey, Mark McLaws, Timothy King, David Burdick